Karhan, O. Et Al. 2025. Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort Study. Oncology (Switzerland) , vol.103, no.6 , 498-507.

Karhan, O., İleri, S., Urakçl, Z., Arvas, H., Klllç, D. K., Sezgin, Y., ... Erçek, B. M.(2025). Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort Study. Oncology (Switzerland) , vol.103, no.6, 498-507.

Karhan, Ogur Et Al. "Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort Study," Oncology (Switzerland) , vol.103, no.6, 498-507, 2025

Karhan, Ogur Et Al. "Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort Study." Oncology (Switzerland) , vol.103, no.6, pp.498-507, 2025

Karhan, O. Et Al. (2025) . "Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort Study." Oncology (Switzerland) , vol.103, no.6, pp.498-507.

@article{article, author={Ogur Karhan Et Al. }, title={Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort Study}, journal={Oncology (Switzerland)}, year=2025, pages={498-507} }